Answers are grounded in this paper and cite their sources.
Immunosuppressants, including calcineurin inhibitors and corticosteroids, are used during pregnancy to treat autoimmune diseases and prevent transplant rejection. Their use requires balancing maternal benefits against potential fetal toxicity, as calcineurin inhibitors are nephrotoxic in adults and cross the placenta. This study investigated whether immunosuppressants induce toxicity or affect early differentiation of the human fetal kidney. Human fetal kidneys (7–14 weeks of development) obtained following elective abortions were analyzed for gene expression patterns. Kidney fragments were exposed for seven days to increasing concentrations of immunosuppressants, alone or in combination. Toxicity and developmental effects were evaluated by flow cytometry, immunohistochemistry, and quantitative PCR. We first characterized the expression of genes encoding proteins of the calcineurin signaling pathway by in situ hybridization. Although expression signatures differed, most genes were detected in interstitial cells. High concentrations of cyclosporine impaired cell viability, proliferation, differentiation, glomerular density, and depleted renin-positive cells. Tacrolimus and prednisone, alone or combined, produced subtler effects, mainly on differentiation. Their combination slightly decreased proliferation and glomerular density. Overall, immunosuppressants did not induce acute toxicity at biologically relevant concentrations. However, the sensitivity of renin-positive cells warrants further investigation, including cardiovascular and renal follow-up in experimental models and mother–child cohorts.
No takes yet. Share an insight, caveat, or question.
BABIN et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: